KOCH KEVIN (CIK 1185829) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-14). Recent activity: Sell EWTX (8,782 shares), Buy EWTX (21,875 shares), Buy EWTX (17,969 shares), Sell EWTX (8,276 shares), Sell EWTX (913 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Sell | 8,782 | $383,254 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Buy | 21,875 | $0 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Buy | 17,969 | $0 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Sell | 8,276 | $361,315 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Sell | 913 | $40,473 |
| 2025-08-14 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Buy | 17,968 | $0 |
| 2025-08-14 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Sell | 7,972 | $106,745 |
| 2025-05-07 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Buy | 10,417 | $0 |
| 2025-05-07 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Sell | 4,276 | $70,340 |
来源：SEC Form 4 申报文件 · 截至 2026-08-14